Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice

BrightOutcome

Status and phase: Completed; Phase 2; Phase 1

Conditions: Breast Cancer

Treatments: Other: Report symptoms via web or phone-based system

Study type: Interventional

Funder types: Industry; NIH

Identifiers

NCT01108315

NCI

HC4ext

Details and patient eligibility

About

Cancer symptoms due to disease progression or side effects caused by cancer treatment are prevalent. Most cancer patients are treated in outpatient settings. Patients may be provided with patient education materials and counseled on anticipated side effects while being provided with different self-management options and warnings regarding when medical care is required. Despite these efforts, many people feel set adrift in having to self-manage treatment and illness related symptoms at home resulting in a sense of burden for the patient and the caregiver.

When the patient does visit the doctor, they increasingly are asked questions to elicit information about symptoms and performance using structured questionnaires that are shown to give reproducible, meaningful, quantitative assessments of how patients feel and how they function-measures that are called patient reported outcomes or PROs. The questionnaires used to collect this information are called PRO instruments. The use of PRO instruments is part of a general movement toward the idea that the patient, properly queried, is the best source of information about how he or she feels. The goal of using PRO measures is to provide better information to doctors and patients so that the best treatment for patients can be determined.

PURPOSE: To reduce the isolation of patients/caregivers from the medical care team and to improve patient/provider communication and clinical decisions by keeping documented daily reports of patient symptoms online, having notifications sent to the medical team of moderate to severe symptoms and by reviewing these reports at clinic visits with the medical staff.

Enrollment: 138 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female, breast oncology patient
• Breast cancer diagnosis
• Expected chemotherapy regimen of at least 3-4 months
• Sufficient cognitive ability and psychological stability in the opinion of treating physician
• Fluent in spoken and written English
• 18 years of age or older
• Outpatient
• Life expectancy > 6 months as estimated by treating physician
• Informed of the investigational nature of this study and provided informed consent.
• Has access to either a phone or the internet

Exclusion criteria

• Is not female, nor a breast oncology patient
• Does not have breast cancer diagnosis
• Expected chemotherapy regimen is less than 3-4 months
• Does not have sufficient cognitive ability and psychological stability in the opinion of treating physician
• Is not fluent in spoken and written English
• Is younger than 18 years of age
• Inpatient
• Life expectancy < 6 months as estimated by treating physician
• Is not informed of the investigational nature of this study and does not provide informed consent.
• Does not have access to either a phone or internet.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

138 participants in 2 patient groups

Intervention

Experimental group

Description:

The participant used the web and/or phone-based PRO reporting symptoms to enter symptoms twice a week at minimum.

Treatment:

Other: Report symptoms via web or phone-based system

Usual Care

No Intervention group

Description:

The participants on this arm do not record their symptoms. They report symptoms as they would under usual care.